Incidence of early adverse events following covishield (ChAdOx1 nCoV-19) vaccination: A prospective study
Background: Minor adverse event following immunizations (AEFIs) are often underreported and self-treated. This study aimed to collect information regarding any and every probable adverse event experienced by the recipient of Covishield vaccine up to 10 days following the first and second dose of vac...
Saved in:
Main Authors: | Gajanan D Velhal (Author), Yash V Kamath (Author), Ansh S Agrawal (Author), Devanshi S Vora (Author), Vaibhav R Dwivedi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lymphadenopathy subsequent to Covishield (ChAdOx1 nCoV-19) Corona virus vaccine: ultrasound findings and clinical implications
by: Soumya Swaroop Sahoo, et al.
Published: (2022) -
Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021
by: Yao Rodion Konu, et al.
Published: (2021) -
Adverse events following COVISHIELD (ChAdOx1nCoV-19) vaccination among health care workers in Sri Lanka; a multi-centre cross sectional survey
by: S.R. Manilgama, et al.
Published: (2022) -
IgA Vasculitis Following ChAdOx1 nCoV-19 Vaccination
by: Manabendra Basu, et al.
Published: (2024) -
Erythrodermic psoriasis following ChAdOx1 nCOV-19 vaccination: A case report
by: Pei-Tzu Lin, et al.
Published: (2022)